Literature DB >> 28670999

Biological variation of holotranscobalamin and cobalamin in healthy individuals.

Mette Brokner1, Helle Borgstrøm Hager1, Morten Lindberg1.   

Abstract

Data on biological variation for cobalamin and holotranscobalamin (holoTC) are limited. The aim of this study was to determine within-subject (CVI) and between-subject (CVG) biological variations for these analytes in a healthy population. We collected blood samples from 15 healthy volunteers (12 women and three men, 22-66 years) on the same weekday for 10 consecutive weeks. Serum samples were stored at -80 °C until analysis in duplicate in a single analytical run. The CVI and CVG were estimated by nested ANOVA. The CVI (95% CI) for cobalamin and holoTC was 6.7% (5.7-7.7) and 13.0% (11.5-15.0), respectively. The corresponding CVG was 24.1% (16.4-36.0) and 24.6% (16.3-37.7). The analytical variation (CVA) (95% CI) was 3.5% (3.2-4.0) for cobalamin and 2.4% (2.1-2.6) for holoTC. The index of individuality (II) was low (<0.6) for both cobalamin and holoTC and the reference change value (RCV) was 20.1% for cobalamin and 36.6% for holoTC. Our study describes the components of biological variation of cobalamin and holoTC in a healthy population, contributing to a better clinical interpretation of these biomarkers.

Entities:  

Keywords:  Vitamin B12; biological variation; cobalamin; healthy volunteers; holotranscobalamin; humans; index of individuality; reference change value

Mesh:

Substances:

Year:  2017        PMID: 28670999     DOI: 10.1080/00365513.2017.1335881

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  3 in total

1.  Transcellular transport of cobalamin in aortic endothelial cells.

Authors:  Luciana Hannibal; Keerthana Bolisetty; Armend Axhemi; Patricia M DiBello; Edward V Quadros; Sergey Fedosov; Donald W Jacobsen
Journal:  FASEB J       Date:  2018-05-09       Impact factor: 5.191

2.  Evolution of plasma vitamin B12 in patients with solid cancers during curative versus supportive care.

Authors:  Valentin Lacombe; Anne Patsouris; Estelle Delattre; Carole Lacout; Geoffrey Urbanski
Journal:  Arch Med Sci       Date:  2021-09-03       Impact factor: 3.318

3.  Delayed Processing of Chilled Whole Blood for 24 Hours Does Not Affect the Concentration of the Majority of Micronutrient Status Biomarkers.

Authors:  Kerry S Jones; Sarah R Meadows; Karen Chamberlain; Damon A Parkington; Dave Collins; Polly Page; Albert Koulman
Journal:  J Nutr       Date:  2021-11-02       Impact factor: 4.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.